-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Insiders Who Sold Hims & Hers Health, Inc.'s (NYSE:HIMS) Earlier Year May Find Some Solace in the 13% Drop
Insiders Who Sold Hims & Hers Health, Inc.'s (NYSE:HIMS) Earlier Year May Find Some Solace in the 13% Drop
Hims & Hers Health, Inc.'s (NYSE:HIMS) value has fallen 13% in the last week, but insiders who sold US$5.9m worth of stock over the last year have had less success. Given that the average selling price of US$5.50 is still lower than the current share price, insiders would probably have been better off keeping their shares.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
Check out our latest analysis for Hims & Hers Health
The Last 12 Months Of Insider Transactions At Hims & Hers Health
In the last twelve months, the biggest single sale by an insider was when the insider, Jack Abraham, sold US$5.5m worth of shares at a price of US$5.55 per share. That means that an insider was selling shares at slightly below the current price (US$5.78). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 7.5% of Jack Abraham's holding.
In the last twelve months insiders purchased 141.40k shares for US$719k. But insiders sold 1.07m shares worth US$5.9m. In total, Hims & Hers Health insiders sold more than they bought over the last year. They sold for an average price of about US$5.50. It's not too encouraging to see that insiders have sold at below the current price. But we wouldn't put too much weight on the insider selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
NYSE:HIMS Insider Trading Volume September 20th 2022I will like Hims & Hers Health better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Hims & Hers Health Insiders Are Selling The Stock
The last three months saw some Hims & Hers Health insider selling. Independent Director Lynne O'Keefe divested only US$44k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the volume sold is so low that it really doesn't bother us.
Insider Ownership
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Hims & Hers Health insiders own 16% of the company, currently worth about US$196m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
What Might The Insider Transactions At Hims & Hers Health Tell Us?
Our data shows a little more insider selling, but no insider buying, in the last three months. But given the selling was modest, we're not worried. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Hims & Hers Health insiders selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For example - Hims & Hers Health has 1 warning sign we think you should be aware of.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hims&Hers Health,Inc.(纽约证券交易所股票代码:HIM)的市值在过去一周下跌了13%,但去年出售了价值590万美元股票的内部人士却没有那么成功。考虑到5.50美元的平均售价仍低于当前股价,内部人士可能会更好地保留他们的股票。
虽然我们永远不会建议投资者应该完全根据公司董事的所作所为做出决定,但我们确实认为,密切关注内部人士的所作所为是完全合乎逻辑的。
查看我们对Hims和Hims Health的最新分析
Hims&Hers Health过去12个月的内幕交易
在过去12个月里,内部人士出售的最大单笔交易是内部人士杰克·亚伯拉罕以每股5.55美元的价格出售了价值550万美元的股票。这意味着一位内部人士以略低于当前价格(5.78美元)的价格出售股票。我们通常认为,如果内部人士一直在抛售,特别是如果他们以低于当前价格的价格抛售,那就是负面的,因为这意味着他们认为更低的价格是合理的。然而,请注意,卖家可能有各种各样的理由出售,所以我们不能确切地知道他们对股价的看法。我们注意到,最大的单笔出售只是杰克·亚伯拉罕所持股份的7.5%。
在过去的12个月里,内部人士以71.9万美元的价格购买了141.4万股。但内部人士出售了107万股,价值590万美元。总体而言,Hims&Hers Health Insiers去年卖出的东西超过了他们购买的东西。它们的平均售价约为5.5美元。看到内部人士以低于当前价格的价格出售,这并不太令人鼓舞。但我们不会对内幕出售给予太多关注。你可以看到过去一年的内幕交易(由公司和个人),如下图所示。通过点击下面的图表,你可以看到每一笔内幕交易的准确细节!
纽约证券交易所:HIM内幕交易量2022年9月20日如果我看到一些大的内部收购,我会更喜欢他和她的健康。在我们等待的时候,看看这个免费最近有大量内幕收购的成长型公司名单。
Hims&Hers Health内部人士正在抛售股票
在过去的三个月里,Hims&Hers Health出现了一些内幕出售。在此期间,独立的董事林恩·奥基夫只出售了价值44K美元的股票。看到内幕销售或缺少最近的买家都不是件好事。但是销售量太低了,我们真的不介意。
内部人持股
看看一家公司的内部人持股总数,可以帮助你了解他们是否与普通股股东很好地结合在一起。我认为,如果内部人士持有该公司大量股份,这是一个好兆头。Hims&Hers Health内部人士拥有该公司16%的股份,根据最近的股价,目前价值约1.96亿美元。这种由内部人士持有的重大所有权通常确实增加了公司以所有股东的利益运营的机会。
Hims&Hers Health的内幕交易可能告诉我们什么?
我们的数据显示,在过去的三个月里,更多的是内幕出售,但没有内幕购买。但考虑到销量不大,我们并不担心。很高兴看到高水平的内部人士持股,但回顾过去一年,我们并没有从Hims&Hers Health Insiers的出售中获得信心。因此,这些内幕交易可以帮助我们建立一个关于股票的论文,但了解这家公司面临的风险也是值得的。例如-Hims&Hers Health有1个警告标志我们认为你应该意识到。
如果你更愿意看看另一家公司--一家财务状况可能更好的公司--那么不要错过这一点免费列出了一些有趣的公司,这些公司拥有高股本回报率和低债务。
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前负责公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧